Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 5, 2022
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
Thu, August 4, 2022
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $122 on, Aug 4th, 2022
Joseph Schwartz of SVB Leerink, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $115 to $122 on, Aug 4th, 2022.
Joseph has made no other calls on BMRN in the last 4 months.
There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andreas Argyrides of "Wedbush" Initiated at Hold and Held Target at $70 on, Monday, June 13th, 2022
These are the ratings of the 2 analyists that currently disagree with Joseph
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $110 on, Wednesday, July 13th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Monday, June 6th, 2022
